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Rehnberg*
Appropriate regulation ofreproductive processes are dependent upon the integrity ofpituitary function.
In this selected review, we evaluate the evidence that certain environmental compounds exert their effect
on reproductive function via a direct action on the pituitary gland. We also discuss examples ofchanges
in pituitary hormone secretion that occur in response to changes in neuronal or gonadal control of the
pituitary. A limited number of studies suggest that measures of pituitary hormone secretion provide an
early and sensitive measure of a compound's potential effects on the reproductive system. However, the
most striking aspect ofthis area is the sparse and inconsistent information describing pituitary function
following exposure to environmental pollutants.
Introduction
The cells within the pituitary must respond to con-
tinuously changing CNS and gonadal signals and pro-
vide the appropriate moment-to-moment responses. As
such, changes in pituitary hormone secretion serve to
integrate a number of the complex mechanisms asso-
ciated with successful reproduction. It would, there-
fore, be expected that environmental compounds which
affect reproductive performance may do so because pi-
tuitary function is altered. However, studies of repro-
ductive toxins frequently ignore measures of pituitary
or hypothalamic-pituitary function in response to treat-
ment. Theoretically, certain classes ofcompounds could
affect pituitary function directly by altering cellular ac-
tivity and hormone secretion. Other compounds could
affect pituitary function indirectly by modifying CNS
and/or gonadal hormone stimulation of the cells. Still
others could have both direct and indirect effects. In
this selected review, we shallexamine theevidence that
pituitary hormone secretion is altered by reproductive
toxins and the extent to which such changes represent
the primary mechanism through which the toxin influ-
ences reproductive capacity.
There is substantial support for a direct pituitary ef-
fect for estrogenic compounds, while therapeutic drugs
and substances ofabuse affect reproduction principally
bymodifyingCNSfunction. Also, thereisgood evidence
that certain compounds such as the pesticide dibromo-
chloropropane (DBCP) andthenonsteroidalantifertility
agent 1,2-dimethane sulfonate (EDS) exert their pri-
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mary influence on the testis and as a consequence alter
pituitary activity (1-3). Nevertheless, there is little
substantive information describing the site of the pri-
mary effect of a variety of other xenobiotics or toxic
metal cations on brain-pituitary-gonadal function, even
though many ofthese compounds are known to modify
reproductive capacity.
Estrogenic Compounds
Many environmental compounds have been found to
possessestrogenicactions. Thosethathavereceivedthe
most attention over the last two decades, in terms of
theireffect onthereproductive system, includethenon-
steroidalestrogen, diethylstilbestrol (DES), andcertain
chlorinated hydrocarbon pesticides (chlordecone and
methoxychlor) (4). DES, methoxychlor and chlorde-
cone, as well as the mycotoxin zearalenone (5), have all
been reported to cause infertility in adult laboratory
and domestic animals. Exposure ofnewborn femalerats
to estrogens markedly perturbs reproductive processes
in later life, presumably by alteringthe development of
the neural mechanisms regulating gonadotropin secre-
tion. DES, methoxychlor, chlordecone, or zearalenone
administered during the critical periods of sexual dif-
ferentiation will also cause persistent alterations in re-
productive development (6-9). In humans, administra-
tion of DES for threatened abortion in women was
responsible for a number of reproductive problems in
the offspring ranging from infertility to vaginal adeno-
carcinoma (10).
Investigations in the neonatal rat also indicate that
analogs ofDDTotherthanmethoxychlor, i.e., 1-(o-chlo-
rophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane (o,COOPER, GOLDMAN, AND REHNBERG
p'-DDT), mayalsohave estrogenic activityattheneuro-
endocrine level. Heinrichs et al. (11) found that rats
giveno,p'-DDTasneonates exhibited advancedpuberty
(vaginal opening), persistent vaginal estrus after a pe-
riod of normal cycling, follicular cysts, and a reduction
in the number of corpora lutea (anovulation). Admin-
istration of these compounds to immature or ovariec-
tomized female animals evokes responses in the uterus
or oviduct similar to those seen after administration of
classical estrogens, such as estradiol (4). Based on this
assay, methoxychlor and o,p'-DDT have been shown to
be estrogenic in a number of species (i.e., rat, mouse,
mink, quail and chicken) (4,12). This effect appears to
be directly on the uterine tissue and not through the
adrenals, as it is not abolished by adrenalectomy.
DES, chlordecone, methoxychlor, and o,p'-DDT an-
alogs also cause adverse reproductive effects in mam-
malian males. DES has been shown to produce a severe
and prompt depression of the adult male rat brain-pi-
tuitary-gonadal axis (13,14). Chlordecone treatment
was reported by Larson et al. (15) to cause testicular
atrophy in the rat. In man, abnormal sperm counts
among industrial workers suffering from chlordecone
toxicity have been described (16). Hodge et al. (17)
found reductions in testicular size in rats pair-fed a diet
containing 1% technical grade methoxychlor. Gray et
al. (9) treated male rats with methoxychlor from 21
through 80 days of age and found decreased reproduc-
tive performance and altered endocrine parameters in
those animals receiving 100 and 200 mg/kg/day. Tech-
nical grade DDT was also reported to cause occasional
testicular atropy in the rat (18), while Krause et al. (19)
reported damaged spermatogenesis and diminished
numbers of Leydig cells in rats given 200 mg/kg DDT
from the 4th to 23rd day of life.
The mechanisms by which these estrogenic com-
pounds act to disrupt gonadal function remain unclear.
Bulger and Kupfer (4) argue that some of the anti-
gonadaleffectofDDTandmethoxychlormaybedirectly
at the level of the testes. Concentrations as low as 0.4
puM o,p'-DDT and 0.1 ,uM of the active monophenol
methoxychlor derivative, HPTE [2,2-bis(p-hydroxy-
phenyl)-1,1,1-trichloroethane], caused a competitive in-
hibition ofthe binding oftritiated estradiol to testicular
estrogen binding protein (presumably an estrogen re-
ceptor). Purifiedmethoxychlorandp,p'-DDT [1,1-bis(p-
chlorophenyl)-2,2,2-trichloroethane] had no effect on
the estrogen binding protein. These results suggested
that HPTE and o,p'-DDT could possibly influence an-
drogen formation by acting on testicular estrogen re-
ceptors.
The toxic effect of DDT analogs on the male repro-
ductive system might also be mediated through the co-
valent binding ofhighly reactive metabolites to macro-
molecules essential for androgen activity. Bulger and
Kupfer (4) present evidence that DDT analog metabo-
lites do bind to microsomal components in vitro. Ifme-
tabolites such as these are generated in vivo and are
able to reach male sex accessory tissue, they could then
diminish androgen production by binding to essential
components ofandrogen-secreting cells. Such highlyac-
tive metabolites could also cause a more generalized
destruction of male reproductive tissue.
It is also well known that DDT analogs are potent
inducers ofhepatic microsomal monooxygenase activity
in vivo (4). Induction ofthis activity by treatment with
DDT analogs could possibly cause a decrease in testic-
ular androgen as a result of enhanced degradation of
endogenous androgens by the monooxygenase system.
Although these observations are suggestive, the
question remains as to whether these are pharmaco-
logical or physiological effects. The effect of DES on
male reproductive function could be mediated by a di-
rect action of this estrogenic compound on the hypo-
thalamus and pituitary, tissues that arerichin estrogen
receptors (20). Incubation ofthe testis with concentra-
tions of DES that affect reproductive function when
administered in vivo can be without effect on testos-
terone secretion (21). By measuring a number of en-
docrineandmorphologicalchangesfollowingDEStreat-
ment, we found that pituitary LH, FSH, and prolactin
concentrations and serum prolactin levels were altered
significantly at doses too low to induce any change in
testicular weight, serum testosterone, androgen bind-
ing protein or testicular morphology (14,22). We also
found that these changes in pituitary hormone content
and secretion occurred sooner after the initiation of
treatment than anynoticeable change intesticularfunc-
tion (22,23,). These data would argue that the pituitary
or hypothalamic-pituitary tissue is a primary target for
the toxic effects of low doses of estrogenic compounds
onthereproductive system. Athigherdoses, thesecom-
pounds may affect both the hypothalamic-pituitary axis
and the gonads directly. An initial estrogenic effect on
the hypothalamus and pituitary was also noted in a
study using methoxychlor (24,25). Doses of methoxy-
chlorthat had no detectable effect ontesticularfunction
or reproductive performance in the male rat (25 and 50
mg/kg/day) produced a small elevation in serum prolac-
tin and a large increase in pituitary prolactin concen-
tration. Using an in vitro perifusion system, a signifi-
cant dose-related increase in prolactin release from
pituitaries obtained from treated animals was also ob-
served.
Curiously, methoxychlor and DESwerefoundtohave
opposite effects on pituitary weight (24). Although both
compounds enhanced pituitary prolactin concentration
and prolactin release, raising the dose of DES caused
a progressive increase in pituitary weight. Methoxy-
chlor, on the other hand, resulted in a significant de-
crease in pituitary weight (25,26). This would indicate
that these two estrogenic compounds are having a dif-
ferential effect on the pituitary and/or hypothalamic-
pituitary axis. Another unexpected finding in pituitary
hormonal function was reported by Huang and Nelson
(27). These investigators studied the effect of chlorde-
cone on LH secretion in response to GnRH in cultured
pituitarycells. Theyfoundthatchlordeconeaffected LH
release in a manner opposite to that observed with es-
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tradiol, suggestingthatinthepituitarychlordecone acts
as an antiestrogen.
Other xenobiotics reported to have estrogenic effects
upon the uterus include the polychlorinated biphenyls
(28), the antidiabetic compound tolbutamide (29), and
two cathartics, phenolphthalein and phenophthalol (28).
The cyclosiloxanes (used in various applications, includ-
ing cosmetics) have also been found to possess estro-
genic properties. Cyclosiloxane caused female rats to
remaininmetestrus ordiestrusforthedurationoftreat-
ment (30). Pregnant rats treated before implantation
with cyclosiloxane failed to demonstrate ova implanta-
tion. LeVier and Jankowiak (31) found that treatment
of mature males with organosiloxane (33 mg/kg for 7
days) diminished ventral prostate and seminal vesicle
weights. Treatmentwith 10mg/kg/dayfor7dayscaused
a significant decrease in serum testosterone values.
Other findings following cyclosiloxane administration
(as low as 0.1 mg/kg/day), were pituitary enlargement
and an increase in pituitary prolactin, LH, and FSH.
In summary, there are a number of environmental
compounds that possess estrogenic activity. For those
that have been evaluated in more detail, it appears that
significant changes in pituitary function do occur fol-
lowing treatment and that such changes are involved in
the alteration of reproductive function. It is possible
that with low doses this effect on the pituitary may be
the sole (or at least primary) mechanism responsible for
altered reproductive capacity. However, at higher
doses a commensurate, direct testicular effect may be
involved.
Therapeutic Drugs and Drugs of
Abuse
Many classes of drugs exert an inhibitory action on
pituitary function. Forthe most part, these drugs mod-
ify hypothalamic control ofpituitary hormone secretion
byaltering CNS neurotransmitter and neuropeptide ac-
tivity. Consequently, these changes in LH, FSH, and
prolactin secretion result in adverse side effects on the
reproductive system, including changes in libido, im-
paired gonadal function, and loss of fertility.
The effects of various therapeutic agents on repro-
ductive function are well known. These drugs may
either depress CNS activity (i.e., anesthetics, analge-
sics, and tranquilizers) or stimulate it (i.e., antidepres-
sants and hallucinogens). In fact, a variety of such
agents are often used to probe the central control of
neuroendocrine function.
There is ample evidence that certain drugs of abuse
alter reproductive function. For example, it has been
shown that in rats and mice A-9-tetrahydrocannabinol
(A-9-THC), the major psychoactive component of mar-
ijuana, significantly reduces LH, FSH, prolactin, and
testosterone concentrations inthe blood and causes dec-
rements in sexual organ weights (32,33). Correspond-
ingly, studies in the rhesus monkey have shown that a
single injection of A-9-THC produces a long-lasting
depression in gonadotropin levels (34). In humans, sim-
ilar reports ofdecreased testosterone levels and signif-
icant changesinspermcount andmorphologyhavebeen
reported, although there is not general agreement in
this regard.
In the female rat, A-9-THC has been shown to sup-
press serum gonadotropin secretion (35) and abolish es-
trous cyclicity (36). A-9-THC was also found to retard
sexual development, as evidenced by a delayed ap-
pearance of estrus and ovulation when daily treatment
was initiated at 27 days of age (37). This alteration in
puberty may reflect the depressed levels ofserum pro-
lactin present in A-9-THC-treated females (38), as pro-
lactin is critical for normal pubertal development (39).
A-9-THC has also been found to disrupt ovulatory func-
tion in primates (40).
The influence of A-9-THC on pituitary function is
likely mediated through this compound's action on the
CNS. The decrease in serum gonadotropins and testos-
terone levels, following acute A-9-THC treatment, can
be reversed by treatment with either human chorionic
gonadotropin (hCG) orgonadotropin releasinghonnone
(GnRH) (41). Similarly, Hughes etal. (38) reportedthat
the fall in prolactin secretion observed after A-9-THC
treatment in vivo was not seen when the pituitary was
exposed to A-9-THC in vitro. However, it has not been
determined whether prolonged treatment with A-9-
THC invivo would resultinmodified pituitaryhormone
concentration or release, or whether such changes are
reversible.
The opiates also appear to exert their primary effect
onthehypothalamic-pituitary axis. Suchchangesincen-
tral regulation ofthe neuroendocrine axis result in dys-
function ofthe gonads and sex accessory organs in both
man and animals. Clinical manifestations, such as de-
creased sexual desire and performance, menstrual ir-
regularities and infertility, and increased fetal loss
among narcotic users are attributed to altered gonadal
functions (41). In laboratory animals, significant alter-
ations in pituitary and gonadal functions have been re-
ported, along with functional and structural changes in
the integrity of the secondary organs, primarily the
seminal vesicles and prostate gland (42).
The endogenous brain opioids have been shown to be
highly concentrated in the hypothalamus and closely
associated with aminergic neurons and those containing
GnRH, as well as with steroid-concentrating neurons
(43). Meites et al. (44) reported that a single injection
of 2, 10, or 15 mg morphine sulfate caused a decrease
in LH levels without chan ging serum FSH. Similarly,
a single injection of met -enkephalin also decreased
serum LH, but not FSH. In both instances, naloxone
reversed this opiate's effect. Itis also significanttonote
that treatment with naloxone alone caused an increase
in serum LH and FSH.
In early reports, morphine administration was shown
to block LH release and ovulation during the rat's es-
trous cycle, and this action could be reversed by con-
comitant administration ofnaloxone (45). In a more re-
cent study (46) morphine was infused IV at 1400 hr on
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proestrus. Morphine delayed the rise in serum LH by
approximately 2 hr and lowered the peak LH values as
compared with saline-injected controls. This inhibitory
effect ofmorphine on LH release again was completely
reversed byadministration ofnaloxone. Naloxone alone
did not alter the peak ofthe LH surge, but maintained
significantly higher serum LH levels than controls dur-
ing the subsequent decline of this hormone. Neither
morphine nor naloxone altered the pattern ofthe FSH
surge, but naloxone completely inhibited the prolactin
surge.
Kumaretal. (47)observedthatboththehypothalamic
and pituitary content of the endogenous opioid met5-
enkephalin was very high on the morning of proestrus
in rats, but decreased significantly that afternoon and
on estrous day. They speculated that the fall in met5-
enkephalin ontheafternoonofproestrusmaycontribute
to the surge of LH and FSH, whereas the high levels
ofthe opioid on the morning ofproestrus were involved
in the rise ofprolactin.
Sylvester et al. (48) evaluated pituitary function in
ovariectomized females treated with estrogen and pro-
gesterone. Morphine completely inhibited the LH and
FSH surges on the day of drug treatment, but on the
following day, a large rebound was observed. In con-
trast, naloxone administration caused a significantly
greater surge ofLH and FSH on the day ofdrugtreat-
ment, while completely suppressing such surges on the
following day. This difference on the second day did not
appeartobeduetodifferences inpituitarygonadotropin
concentrations, because treated and control groups re-
leased as much hormone in response to GnRH. In long-
term ovariectomized rats, morphine decreased the
height ofthe pulsatile LH release and the frequency of
the pulses. Naloxone increased the pulse height, but
had no effect on pulse frequency (44).
In narcotic addicts, testosterone and LH levels are
markedly depressed (49,50). According to clinical re-
ports, heroin addictsexperience both diminished sexual
drive and impaired sexual function. Sperm count and
spermmotilityarealsodecreased. Theexactmechanism
bywhichnarcoticssuppress sexualfunctionisunknown.
The endorphins may have a role in influencing sexual
behavior, butitisalsolikelythatdecreasedtestosterone
levels are responsible for the lowered libido. It is clear
that the narcotic drugs can suppress gonadotropin se-
cretion and stimulate the secretion ofprolactin. Both of
these effects are likely to be inhibitory to male sexual
function (51).
Metals
The metal cations represent another class ofenviron-
mental compounds known to alter reproductive capac-
ity, although the effect that these cations have on pi-
tuitaryfunctionremainstobedetermined. Sincecertain
metal ions affect CNS neurotransmitter activity (52,53)
and accumulate in the pituitary followinginjection (54),
it becomes apparent that altered pituitary function
could contribute to the toxic effects observed on the
reproductive system. Below, we discuss the data avail-
able on three of the heavy metals and their possible
influences upon pituitary function.
Cadmium
Single subcutaneous injections of 1 or 5 mg cadmium
chloride to adult male rats cause a significant reduction
in the weights ofthe testis, epididymidis, vas deferens,
ventral prostrate, and seminal vesicles (55,56) as well
as a decrease in hCG-stimulated testosterone secretion
(57). Sperm population in the vas deferens, caput and
caudaepididymidis wereseverelyreduced. Sexualdrive
andfertilitywereunaltered 7or 15daysaftertreatment
with 1 mg cadmium chloride. However, there was a
decrease in sexual activity rangingfrom altered behav-
ioral activitytototal sterility in animalsreceiving5mg.
Circulating testosterone and 5 a-dihydrotestosterone
were suppressed, whereas androstenedione concentra-
tion remained unaltered (56). It appears that cadmium
chloride not only affects spermatogenesis, but also in-
hibits androgen production.
The marked necrosis inthe testiswhich followstreat-
mentwith cadmiumsaltsprobablyresultsfromasevere
reduction in testicular blood flow and an increase in
permeability of the blood vessels and the blood-testis
barrier (58). In rats, pituitary LH and FSH secretion
are also affected. Allanson and Deanesly (59) reported
"castration-like" changes in the gonadotrophs during
the period of testicular necrosis. Similarly, Gray et al.
(60) reported increased serum FSH levels in male rats
treated with a single injection of cadmium chloride be-
tween 49 and 70 days ofage and sacrificed at 9 months
ofage. Such observations would indicate that cadmium
has its primary effect on the testis and that changes in
LH and FSH secretion occuras aresult ofaltered feed-
back emanating from the damaged testes.
In female mice and rats, cadmium has been reported
to cause fetal resorption and malformations (61). In the
female hamster, cadmium chloride was reported to
block ovulation and produce prolonged alterations in
ovarian cyclicity (62). Whether these effects are a con-
sequence of altered pituitary or ovarian function is un-
clear. However, cadmium chloride injections near the
time of the preovulatory LH surge were more disrup-
tive to subsequent ovarian cycles than those given dur-
ing other stages of the estrous cycle, indicating that
pituitary hormone secretion may have been altered.
Nickel
Adverse effects of nickel on reproductive processes
have been reported in rats after the administration of
soluble nickel salts. Hoey (63) studied the acute and
chronic influence on rat testes of nickel sulfate given
subcutaneouslyat0.04mmole/kg. At 18hrafterasingle
dose, shrinkage ofcentral tubules, hyperemia ofinter-
tubular capillaries, and disintegration of spermatozoa
were observed. The effects of multiple doses were an
extension of the acute effects and included further
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shrinkage of tubules, disintegration of spermatocytes
and spermatids, and cytotoxic effects on Sertoli cells.
The changes were reported to be nearly completely re-
versible. Inhibition of spermatogenesis has also been
observed afterdailyoraladministration ofnickelsulfate
at 25 mg/kg. Reductions in the number of basal cells
within the tubules and in the number of tubules that
contained spernatozoa were reported. Male rats given
nickel sulfate at 25 mg/kg for 120 days were apparently
infertile, inasmuch as no pregnancies resulted when the
males were caged with females in estrus.
In the rabbit, Parker and Sunderman (54) found that
of the various tissues studied, the concentrations of
nickel in the pituitary were second only to those in the
kidneys. This observation was independently confirmed
by Clary (64) in his investigation of the distribution of
nickel in guinea pig and rat tissues. The finding that
nickel is heavily localized in the pituitary may have
physiologic significance. Clemons and Garcia (65) found
that a single subcutaneous injection of nickel chloride
(10 and 20 mg/kg) in the rat led to a profound and con-
sistent increase of circulating prolactin after one day
which lasted for four additional days. There was also
an elevation ininsulin levels that appeared 1 and 2 days
post-injection. The nickel-induced prolactin rise could
be abolished by a simultaneous administration of the
dopamine receptor blocker, CB154. In vitro incubation
of pituitaries from rats that received 20 mg/kg nickel
48 hr prior to sacrifice released more prolactin into the
culturemediumandcontained moreprolactininthefinal
tissue homogenate than did pituitaries from control an-
imals. Also, the hypothalamic extracts obtained from
nickel-injected rats weretested invitro withnormal rat
pituitaries in an effort to evaluate theirabilityto inhibit
prolactin secretion. Thehypothalamic extracts obtained
from treated animals possessed less prolactin-inhibiting
ability (dopamine concentration?) than the extracts ob-
tained from control rats. The results show that nickel
chloride has effects on the endocrine system that last
considerably longer than previously reported. These
data also demonstrate that the influence ofnickel chlo-
ride upon the reproductive system may be mediated
throughtheneuroendocrine changesand, insteadofspe-
cifically inhibitingprolactin secretion fromthe pituitary
as previously reported in short-term studies (66,67),
nickel chloride promotes high circulating prolactin lev-
els lasting 1 to 4 days.
The fact that nickel, as well as other metal cations,
can affect pituitary function through a direct action has
been demonstrated in other studies using in vitro peri-
fusion techniques. The addition of nickel chloride (50
,uM), zinc chloride (50 or 200 ,M), or cobalt chloride
(100 pM) to the perifusion medium resulted in a dra-
matic decrease in prolactin release (68-70). These ob-
servations demonstrate a direct effect ofthe metal ions
onpituitary hormone secretion. Whetherornotthecon-
centrations of the metal ions used in these studies ap-
proximate the concentrations reachingthe pituitary fol-
lowing traditional routes of exposure remains to be
determined.
Lead
Sokol et al. (71) evaluated the effect of lead on re-
productive function in order to ascertain what repro-
ductive abnormalities occurin experimental animalsex-
posed to low levels oflead. Fifty-two-day-old male rats
were treated with water containing 0.00, 0.1, or 0.3%
leadacetatefor30dayspriortokilling. Bloodleadlevels
werebelowdetectioninthe control, 3p,g/dL inthe 0.1%
and 60 ,ug/dL inthe 0.3% lead acetate group. There was
a significant negative correlation between blood lead
levels and serum and intratesticular testosterone val-
ues. As the level of lead exposure increased, intrates-
ticular sperm counts declined. No changes in serum LH
values were found, but sperm and FSH values were
significantly suppressed after treatment. There was a
decrease in ventral prostate weight, but no differences
in testicular or seminal vesicle weights. The authors
conclude that exposure to lead resulting in whole blood
serum lead values considered acceptable in the work-
place (- 40 jig/dL) causes inhibition oftesticular func-
tion. The failure to demonstrate elevated LH and FSH
in the face of markedly decreased serum testosterone
and ventral prostate weight suggests either a principal
mechanism of action of lead toxicity at the level ofthe
hypothalamic-pituitary axis or a combined defect in-
volving the gonad and hypothalamic-pituitary sites.
Autoradiographic studies have localized lead within
the median eminence ofthe hypothalamus (72). Lead is
known to affect the release of a number of brain neu-
rotransmitters, including norepinephrine and dopa-
mine. Unfortunately, scarce and confficting data have
been reported on the effects of lead on hypothalamic
neurotransmitter concentration and turnover (73).
In a clinical study, Braunstein et al. (74) reported a
blunting of the pituitary response to clomiphene and
gonadotropin-releasing hormone in lead-poisoned men.
These datafurthersupportthe possibilitythatleadtox-
icity impairs hypothalamic-pituitary function.
Althoughreports describingtheeffectofleadonCNS
functionareinconsistent, aregionalanalysisofDAfunc-
tion in the rat reveal changes that would be consonant
with potential changes in dopaminergic (DA) neuro-
transmission and pituitary prolactin secretion. Govoni
et al. (75) evaluated the effect of chronic dietary lead
exposure onthe brainnigrostriatal, mesolimbic andme-
socortical dopaminergic systems. They found no alter-
ations of DA receptors, measured either as dopamine
sensitive adenylate cyclase oras (3H)-spiroperidol bind-
ing. On the other hand, dopamine synthesis appeared
to be reduced in the striatum, unaffected in the sub-
stantia nigra and increased in the nucleus accumbens
and frontal cortex. The increase of DA synthesis ob-
served in the accumbens would be consistent with the
hyperactive behavior that has been reported following
lead intoxication. The effect of lead exposure on the
hypothalamic DA mechanisms regulating prolactin se-
cretion were also studied in rats by measuring the con-
centration of DA and its metabolite DOPAC
(dihydroxyphenylacetic acid) in the hypothalamus,
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along with DA receptor densities in the hypothalamus
andpituitary (76). Decrementsinhypothalamic DOPAC
concentrations and DAreceptor densityinthe pituitary
were found. The decreased DA binding in the pituitary
is consistent with the elevated serum prolactin concen-
trations described in lead-exposed rats (77). These au-
thors argue that decreased DOPAC with normal levels
of DA indicates a lowered DA "tone" in the hypothal-
amus. They further argue that pituitary DA receptors
become "subsensitive" in spite of lower hypothalamic
DA levels and that the interference by lead with the
central neuroendocrine processes may contribute to the
delayed sexual development and decreased reproduc-
tive ability observed during lead intoxication.
Lead has also been reported to alterthyroidfunction,
and this could affect pituitary regulation ofthe gonads.
Bruni et al. (78) noted that hypothyroid humans, mon-
keys, rats, and mice were deficient in gonadotropins
and had irregular or no menstrual and estrous cycles.
Thyroidectomy of male and female rats with intact go-
nads results in a significant decrease in serum LH and
FSH, as well as a decrease in serum testosterone in the
male. Administration ofareplacementdoseofthyroxine
(T4, 2,5 ,ug/100 g body weight) elevated serum LH and
FSH inthe females tothe level ofcontrol, intact values,
and returned serum LH and testosterone to the level
of control males. Since thyroid function is apparently
important fornormalpubertaldevelopmentinthemale,
the effects of thyroidectomy and treatment with thy-
roxine were studied in immature male rats by Chow-
dhury et al. (79). Thyroidectomy was found to inhibit
gametogenesis and Leydig cell development. However,
the effects could be reversed with administration of 10
,ug T4 (injected intraperitoneally daily for 30 days).
In humans, Robins et al. (80) found low values for
serum thyroxine and estimated free thyroxine in 7 of
12 workers referred because ofelevated blood lead lev-
els. They concluded that there is a substantial inverse
relationship between blood lead and serum thyroxine.
This could be overcome with TRH or TSH. Such ob-
servations would be compatible with a central depres-
sion of the thyroid axis, or an alteration in thyroxine
metabolism or binding to proteins.
Other occupational and environmental agents have
been noted to cause depressed thyroid function, includ-
ing the polybrominated biphenyls and carbon disulfide.
Polybrominated biphenyls are associated with an anti-
thyroid and antibody-positive primary hypothyroidism
(81). In workers exposed to carbon disulfide, low T4
values were present in 40% of the individuals tested
(82). In neonatal rats, chlorine dioxide has been re-
ported to depress thyroid function (83), and this com-
pound, which has been suggested as an alternative to
chlorine for drinking water disinfection, has been im-
plicated as a potential antithyroid agent in the monkey
(84). In female mice, treatment with the herbicide, 2,4-
dichlorophenyl-p-nitrophenyl ether(nitrofen) for3 days
caused a dose-related reduction in serumthyroxine lev-
els, althoughtriiodothyronine (T3) wasnotaffected (85).
The importance ofthese changes in thyroid function to
the reproductive axis remains to be explored.
Finally, lead may also have a direct testicular effect.
Wiebe et al. (86) isolated Sertoli cells from the testes
of prepubertal rats and cultured them in the presence
of 2.64 x 10'4 M of lead acetate for 1, 4, 24, 48, 96,
and 144 hr. They found no reduction ofFSH binding or
FSH-induced cyclic AMP after 1-4 hrexposure to lead.
After 24 hr exposure to lead acetate the Sertoli cells
exhibited a 10-20% decrease in FSH binding and cyclic
AMP production, and after 96 hr there was a 75% de-
crease inthese two parameters. Afterinvitro exposure
to lead acetate for48 hr, the steroidogenic activity (pro-
gesterone conversion to steroid metabolites) ofthe Ser-
toli cells was significantly reduced and steroidogenesis
was no longer stimulated by FSH.
Summary
A variety ofenvironmental compounds are known to
have deleterious effects on reproductive function. The
effect that estrogenic compounds and narcotics have on
pituitary function is well documented. The majority of
studies have shown that these substances alter repro-
ductive capacity through their direct action on the pi-
tuitary or alter pituitary function through their action
on neural tissue. In contrast, the extent to which in-
dustrial byproducts and other classes ofxenobiotics af-
fect pituitary function is unknown. This lack of infor-
mation is unfortunate, because changes in pituitary
hormone secretion may prove to be a sensitive index
useful in determining the potential toxic effect that cer-
tain classes of compounds possess. Additionally, since
the neuroendocrine control ofpituitary hormone secre-
tion is well understood, these measures can provide
useful information concerning the mechanisms through
which certain compounds alter reproductive capacity.
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